Gene expression correlates of clinical prostate cancer behavior

Cancer Cell

Volumn 1, Issue 2, 2002, Pages 203-209

  Singh, Dinesh ^a,b   Febbo, Phillip G ^a,b,c   Ross, Kenneth ^c   Jackson, Donald G ^d   Manola, Judith ^a   Ladd, Christine ^c   Tamayo, Pablo ^c   Renshaw, Andrew A ^b,e   D'Amico, Anthony V ^b   Richie, Jerome P ^b   Lander, Eric S ^c   Loda, Massimo ^a,b   Kantoff, Philip W ^a,b   Golub, Todd R ^a,c   Sellers, William R ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

^e BAPTIST HOSPITAL OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER CYTODIAGNOSIS; CANCER INVASION; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC CORRELATION; GENETIC LINKAGE; HUMAN; HUMAN TISSUE; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; PROTEIN MICROARRAY; SCORING SYSTEM; TUMOR DIFFERENTIATION; ADULT; AGED; CLASSIFICATION; DISEASE FREE SURVIVAL; GENE EXPRESSION PROFILING; GENETICS; MALE; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; PROSTATE TUMOR; REPRODUCIBILITY; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; DISEASE-FREE SURVIVAL; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 19044391072     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00030-2     Document Type: Article

References (23)

1. Bhattacharjee, A., Richards, W.G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., et al. (2001). Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. USA 98, 13790-13795.
2. Chetcuti, A., Margan, S., Mann, S., Russell, P., Handelsman, D., Rogers, J., and Dong, Q. (2001). Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array. Prostate 47, 132-140.
3. Chott, A., Sun, Z., Morganstern, D., Pan, J., Li, T., Susani, M., Mosberger, I., Upton, M.P., Bubley, G.J., and Balk, S.P. (1999). Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor. Am. J. Pathol. 155, 1271-1279.
4. Cox, D. (1970). Analysis of Bianary Data (London: Mechuen and Co.).
5. Dhanasekaran, S.M., Barrette, T.R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K.J., Rubin, M.A., and Chinnaiyan, A.M. (2001). Delineation of prognostic biomarkers in prostate cancer. Nature 412, 822-826.
6. Gleason, D. (1966). Classification of prostatic carcinomas. Cancer Chemother. Rep. 50, 125-128.
7. Golub, T.R., Slonim, D.K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J.P., Coller, H., Loh, M.L., Downing, J.R., Caligiuri, M.A., et al. (1999). Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537.
8. Good, P. (2000). Permutation tests: A practical guide to resampling methods for testing hypotheses, Second Edition, S.S.i. Statistics (New York: Springer-Verlag).
9. Greenlee, R.T., Murray, T., Bolden, S., and Wingo, P.A. (2000). Cancer statistics, 2000. CA Cancer J. Clin. 50, 7-33.
10. Man, M., Partin, A.W., Piantadosi, S., Epstein, J.I., and Walsh, P.C. (2001). Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J. Urol. 166, 416-419.
11. Jewett, H.J. (1975). The present status of radical prostatectomy for stages A and B prostatic cancer. Urol. Clin. North Am. 2, 105.
12. Luo, J.H., Yu, Y.P., Cieply, K., Lin, F., Deflavia, P., Dhir, R., Finkelstein, S., Michalopoulos, G., and Becich, M. (2001). Gene expression analysis of prostate cancers. Mol. Carcinog. 33, 25-35.
13. Mehta, C., and Patel, A.T. (1984). Exact significance testing for ordered categorical data. Biometrics 30, 819-825.
14. Perou, C.M., Sorlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., Pollack, J.R., Ross, D.T., Johnsen, H., Akslen, L.A., et al. (2000). Molecular portraits of human breast tumours. Nature 406, 747-752.
15. Pomeroy, S.L., Tamayo, P., Gaasenbeek, M., Sturla, L.M., Angelo, M., McLaughlin, M.E., Kim, J.Y., Goumnerova, L.C., Black, P.M., Lau, C., et al. (2002). Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415, 436-442.
16. Roberts, S.G., Blute, M.L., Bergstralh, E.J., Slezak, J.M., and Zincke, H. (2001a). PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clin. Proc. 76, 576-581.
17. Roberts, W.W., Bergstralh, E.J., Blute, M.L., Slezak, J.M., Carducci, M., Han, M., Epstein, J.I., Eisenberger, M.A., Walsh, P.C., and Partin, A.W. (2001b). Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy. Urology 57, 1033-1037.
18. Sellers, W., and Sawyers, C. (2001). Molecular abnormalities in prostate cancer. In Prostate Cancer: Principles & Practice, P. Kantoff, P. Carroll, and A. D'Amico, eds. (Philadelphia: Lippincott Williams & Wilkins), pp. 53-76.
19. Stamey, T.A., Yang, N., Hay, A.R., McNeal, J.E., Freiha, F.S., and Redwine, E.A. (1987). Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med. 317, 909.
20. Theodorescu, D., Broder, S.R., Boyd, J.C., Mills, S.E., and Frierson, H.F., Jr. (1997). Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate. Cancer 80, 2109-2119.
21. van't Veer, L., Dai, H., Vijver, M.v.D., He, Y., Hart, A., Moa, M., Peterse, H., Kooy, K.v.D., Marton, M., Witteveen, A., Schreiber, G., Kerkhoven, R., Roberts, C., Linsley, P., Bernards, R., and Friend, S. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536.
22. Welsh, J.B., Sapinoso, L.M., Su, A.I., Kern, S.G., Wang-Rodriguez, J., Moskaluk, C.A., Frierson, H.F., Jr., and Hampton, G.M. (2001). Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61, 5974-5978.
23. Wilcoxin, F. (1945). Individual comparisons by ranking methods. Biometrics 1, 80-83.